^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Pancreatic Adenocarcinoma |
| Drug: | cisplatin (DNA synthesis inhibitor) + gemcitabine (DNA synthesis inhibitor) + albumin-bound paclitaxel (Bcl2 inhibitor, Tubulin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Pancreatic Adenocarcinoma: Principles of systemic therapy…Other Recommended Regimens...Gemcitabine + albumin-bound paclitaxel + cisplatin (category 2B)
